These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2439461)

  • 1. [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].
    Rietschel ET; Brade H
    Infection; 1987; 15(2):133-41. PubMed ID: 2439461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].
    Rietschel ET; Brade H
    Infection; 1987; 15 Suppl 2():S76-84. PubMed ID: 2440812
    [No Abstract]   [Full Text] [Related]  

  • 3. [The general and specific properties of Neisseria meningitidis lipopolysaccharide compared to the lipopolysaccharides of other gram-negative bacteria].
    Stukalova NV; Aleksakhina NN; Basnak'ian IA
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Dec; (12):81-7. PubMed ID: 2483484
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical structure, molecular conformation, and bioactivity of endotoxins.
    Seydel U; Schromm AB; Blunck R; Brandenburg K
    Chem Immunol; 2000; 74():5-24. PubMed ID: 10608079
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacterial endotoxin: molecular relationships between structure and activity.
    Rietschel ET; Seydel U; Zähringer U; Schade UF; Brade L; Loppnow H; Feist W; Wang MH; Ulmer AJ; Flad HD
    Infect Dis Clin North Am; 1991 Dec; 5(4):753-79. PubMed ID: 1723739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production, characterization and biological effects of monoclonal antibodies to different parts of the gram-negative lipopolysaccharide core region.
    Appelmelk BJ; Verweij-van Vught M; Brade H; Maaskant J; Schouten W; Thijs B; MacLaren D
    Prog Clin Biol Res; 1988; 272():373-82. PubMed ID: 2455918
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.
    Mascelli MA; Frederick B; Ely T; Neblock DS; Shealy DJ; Pak KY; Daddona PE
    Infect Immun; 1993 May; 61(5):1756-63. PubMed ID: 8478065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins.
    Westphal O; Jann K; Himmelspach K
    Prog Allergy; 1983; 33():9-39. PubMed ID: 6187018
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibodies: technology and application to gram-negative infections.
    Young LS
    Infection; 1984; 12(4):303-8. PubMed ID: 6208152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
    Siber GR; Kania SA; Warren HS
    J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of monoclonal antibody E5 with endotoxin. II. Binding to short- and long-chain smooth lipopolysaccharides.
    Parent JB; Gazzano-Santoro H; Wood DM; Lim E; Pruyne PT; Trown PW; Conlon PJ
    Circ Shock; 1992 Sep; 38(1):63-73. PubMed ID: 1382882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of lipopolysaccharide of gram-negative bacilli in sensitivity and resistance to serum.
    Porat R; Johns MA; McCabe WR
    Prog Clin Biol Res; 1988; 272():103-14. PubMed ID: 2455915
    [No Abstract]   [Full Text] [Related]  

  • 14. [Endotoxins of gram-negative bacteria: chemical structure and biological effect].
    Brade H; Rietschel ET
    Z Gastroenterol; 1986 Sep; 24 Suppl 3():25-31. PubMed ID: 2430368
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to lipopolysaccharides: some diagnostic and protective aspects.
    Fomsgaard A
    APMIS Suppl; 1990; 18():1-38. PubMed ID: 2122911
    [No Abstract]   [Full Text] [Related]  

  • 16. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.
    Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM
    J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of bacterial lipopolysaccharides (endotoxins). Current and future aspects.
    Brade H; Brade L; Rietschel ET
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):151-79. PubMed ID: 3293332
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial lipopolysaccharide and its lipid A component: some historical and some current aspects.
    Westphal O; Lüderitz O; Rietschel ET; Galanos C
    Biochem Soc Trans; 1981 Jun; 9(3):191-5. PubMed ID: 7274542
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipopolysaccharide-protein complexes of the outer membrane of gram-negative bacteria].
    Solov'eva TF; Ovodov IuS
    Bioorg Khim; 1983 Jun; 9(6):725-33. PubMed ID: 6207844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.